ISIN | LU1876525889 |
---|---|
Valor Number | 43467775 |
Bloomberg Global ID | |
Fund Name | Europe Index JS EUR |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | To achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 298.03 EUR | 04.04.2025 |
---|---|---|
Previous Price * | 313.49 EUR | 03.04.2025 |
52 Week High * | 337.21 EUR | 03.03.2025 |
52 Week Low * | 288.18 EUR | 05.08.2024 |
NAV * | 298.03 EUR | 04.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,031,525,162 | |
Unit/Share Assets *** | 5,748,408 | |
Trading Information SIX |
YTD Performance | -1.26% |
31.12.2024 - 04.04.2025
31.12.2024 04.04.2025 |
---|---|---|
YTD Performance (in CHF) | -0.92% |
31.12.2024 - 04.04.2025
31.12.2024 04.04.2025 |
1 month | -9.74% |
04.03.2025 - 04.04.2025
04.03.2025 04.04.2025 |
3 months | -2.57% |
06.01.2025 - 04.04.2025
06.01.2025 04.04.2025 |
6 months | -3.34% |
04.10.2024 - 04.04.2025
04.10.2024 04.04.2025 |
1 year | +0.01% |
04.04.2024 - 04.04.2025
04.04.2024 04.04.2025 |
2 years | +14.86% |
04.04.2023 - 04.04.2025
04.04.2023 04.04.2025 |
3 years | +17.38% |
04.04.2022 - 04.04.2025
04.04.2022 04.04.2025 |
5 years | +20.86% |
14.06.2021 - 04.04.2025
14.06.2021 04.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 2.51% | |
---|---|---|
SAP SE | 2.50% | |
ASML Holding NV | 2.42% | |
Nestle SA | 2.20% | |
AstraZeneca PLC | 2.03% | |
Roche Holding AG | 2.02% | |
Novartis AG Registered Shares | 1.85% | |
HSBC Holdings PLC | 1.84% | |
Shell PLC | 1.77% | |
Lvmh Moet Hennessy Louis Vuitton SE | 1.72% | |
Last data update | 28.02.2025 |
TER *** | 0.163% |
---|---|
TER date *** | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.10% |
Ongoing Charges *** | 0.17% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |